BOSTON ( TheStreet) -- Welcome to the doubleheader FDA advisory panel live blog: The morning panel features Aveo Oncology (AVEO - Get Report) and its kidney cancer drug tivozanib. In the afternoon session, Delcath Systems (DCTH - Get Report) brings the Melblez liver-tumor therapy in front of the FDA's outside experts.
Aveo, Delcath FDA Panel Live Blog
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts